BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

207 related articles for article (PubMed ID: 24057292)

  • 1. An activating mutation in the kinase homology domain of the natriuretic peptide receptor-2 causes extremely tall stature without skeletal deformities.
    Hannema SE; van Duyvenvoorde HA; Premsler T; Yang RB; Mueller TD; Gassner B; Oberwinkler H; Roelfsema F; Santen GW; Prickett T; Kant SG; Verkerk AJ; Uitterlinden AG; Espiner E; Ruivenkamp CA; Oostdijk W; Pereira AM; Losekoot M; Kuhn M; Wit JM
    J Clin Endocrinol Metab; 2013 Dec; 98(12):E1988-98. PubMed ID: 24057292
    [TBL] [Abstract][Full Text] [Related]  

  • 2. An Activating Deletion Variant in the Submembrane Region of Natriuretic Peptide Receptor-B Causes Tall Stature.
    Lauffer P; Miranda-Laferte E; van Duyvenvoorde HA; van Haeringen A; Werner F; Boudin E; Schmidt H; Mueller TD; Kuhn M; van der Kaay DCM
    J Clin Endocrinol Metab; 2020 Jul; 105(7):2354-66. PubMed ID: 32282051
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Intact kinase homology domain of natriuretic peptide receptor-B is essential for skeletal development.
    Hachiya R; Ohashi Y; Kamei Y; Suganami T; Mochizuki H; Mitsui N; Saitoh M; Sakuragi M; Nishimura G; Ohashi H; Hasegawa T; Ogawa Y
    J Clin Endocrinol Metab; 2007 Oct; 92(10):4009-14. PubMed ID: 17652215
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Skeletal overgrowth-causing mutations mimic an allosterically activated conformation of guanylyl cyclase-B that is inhibited by 2,4,6,-trinitrophenyl ATP.
    Dickey DM; Otto NM; Potter LR
    J Biol Chem; 2017 Jun; 292(24):10220-10229. PubMed ID: 28450398
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Overgrowth syndrome associated with a gain-of-function mutation of the natriuretic peptide receptor 2 (NPR2) gene.
    Miura K; Kim OH; Lee HR; Namba N; Michigami T; Yoo WJ; Choi IH; Ozono K; Cho TJ
    Am J Med Genet A; 2014 Jan; 164A(1):156-63. PubMed ID: 24259409
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Molecular and in silico analyses validates pathogenicity of homozygous mutations in the NPR2 gene underlying variable phenotypes of Acromesomelic dysplasia, type Maroteaux.
    Irfanullah ; Zeb A; Shinwari N; Shah K; Gilani SZT; Khan S; Lee KW; Raza SI; Hussain S; Liaqat K; Ahmad W
    Int J Biochem Cell Biol; 2018 Sep; 102():76-86. PubMed ID: 30016695
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Heterozygous mutations in natriuretic peptide receptor-B (NPR2) are associated with short stature.
    Olney RC; Bükülmez H; Bartels CF; Prickett TC; Espiner EA; Potter LR; Warman ML
    J Clin Endocrinol Metab; 2006 Apr; 91(4):1229-32. PubMed ID: 16384845
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Heterozygous mutations in natriuretic peptide receptor-B (NPR2) gene as a cause of short stature in patients initially classified as idiopathic short stature.
    Vasques GA; Amano N; Docko AJ; Funari MF; Quedas EP; Nishi MY; Arnhold IJ; Hasegawa T; Jorge AA
    J Clin Endocrinol Metab; 2013 Oct; 98(10):E1636-44. PubMed ID: 24001744
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Acromesomelic dysplasia, type maroteaux caused by novel loss-of-function mutations of the NPR2 gene: Three case reports.
    Wang W; Song MH; Miura K; Fujiwara M; Nawa N; Ohata Y; Kitaoka T; Kubota T; Namba N; Jin DK; Kim OH; Ozono K; Cho TJ
    Am J Med Genet A; 2016 Feb; 170A(2):426-434. PubMed ID: 26567084
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A human skeletal overgrowth mutation increases maximal velocity and blocks desensitization of guanylyl cyclase-B.
    Robinson JW; Dickey DM; Miura K; Michigami T; Ozono K; Potter LR
    Bone; 2013 Oct; 56(2):375-82. PubMed ID: 23827346
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A loss-of-function mutation in natriuretic peptide receptor 2 (Npr2) gene is responsible for disproportionate dwarfism in cn/cn mouse.
    Tsuji T; Kunieda T
    J Biol Chem; 2005 Apr; 280(14):14288-92. PubMed ID: 15722353
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Regulation of the Natriuretic Peptide Receptor 2 (Npr2) by Phosphorylation of Juxtamembrane Serine and Threonine Residues Is Essential for Bifurcation of Sensory Axons.
    Schmidt H; Dickey DM; Dumoulin A; Octave M; Robinson JW; Kühn R; Feil R; Potter LR; Rathjen FG
    J Neurosci; 2018 Nov; 38(45):9768-9780. PubMed ID: 30249793
    [TBL] [Abstract][Full Text] [Related]  

  • 13. An overgrowth disorder associated with excessive production of cGMP due to a gain-of-function mutation of the natriuretic peptide receptor 2 gene.
    Miura K; Namba N; Fujiwara M; Ohata Y; Ishida H; Kitaoka T; Kubota T; Hirai H; Higuchi C; Tsumaki N; Yoshikawa H; Sakai N; Michigami T; Ozono K
    PLoS One; 2012; 7(8):e42180. PubMed ID: 22870295
    [TBL] [Abstract][Full Text] [Related]  

  • 14. C-type natriuretic Peptide down-regulates expression of its cognate receptor in rat aortic smooth muscle cells.
    Rahmutula D; Gardner DG
    Endocrinology; 2005 Nov; 146(11):4968-74. PubMed ID: 16109786
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Homozygous sequence variants in the NPR2 gene underlying Acromesomelic dysplasia Maroteaux type (AMDM) in consanguineous families.
    Irfanullah ; Umair M; Khan S; Ahmad W
    Ann Hum Genet; 2015 Jul; 79(4):238-44. PubMed ID: 25959430
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The pseudokinase domains of guanylyl cyclase-A and -B allosterically increase the affinity of their catalytic domains for substrate.
    Edmund AB; Walseth TF; Levinson NM; Potter LR
    Sci Signal; 2019 Jan; 12(566):. PubMed ID: 30696704
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Deficiency of Natriuretic Peptide Receptor 2 Promotes Bicuspid Aortic Valves, Aortic Valve Disease, Left Ventricular Dysfunction, and Ascending Aortic Dilatations in Mice.
    Blaser MC; Wei K; Adams RLE; Zhou YQ; Caruso LL; Mirzaei Z; Lam AY; Tam RKK; Zhang H; Heximer SP; Henkelman RM; Simmons CA
    Circ Res; 2018 Feb; 122(3):405-416. PubMed ID: 29273600
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Role of NPR2 mutation in idiopathic short stature: Identification of two novel mutations.
    Hwang IT; Mizuno Y; Amano N; Lee HJ; Shim YS; Nam HK; Rhie YJ; Yang S; Lee KH; Hasegawa T; Kang MJ
    Mol Genet Genomic Med; 2020 Mar; 8(3):e1146. PubMed ID: 31960617
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Short Stature is Progressive in Patients with Heterozygous NPR2 Mutations.
    Hanley PC; Kanwar HS; Martineau C; Levine MA
    J Clin Endocrinol Metab; 2020 Oct; 105(10):3190-202. PubMed ID: 32720985
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Novel pathogenic NPR2 variants in short stature patients and the therapeutic response to rhGH.
    Chen H; Zhang S; Sun Y; Chen J; Yuan K; Zhang Y; Yang X; Lin X; Chen R
    Orphanet J Rare Dis; 2023 Jul; 18(1):221. PubMed ID: 37501190
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.